[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339698-105":59,"doc-detail-339698-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","breast-cancer-stem-cells-and-tumor-heterogeneity-characteristics-and-therapeutic-strategies","Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies","","Breast cancer is among the most frequently diagnosed malignancies worldwide and causes a substantial fraction of cancer deaths in women, driven by marked heterogeneity across histological, molecular, and clinical profiles. Despite common hierarchical organization of tumors, a small fraction of breast cancer stem cells (BCSCs) contributes to progression and therapeutic failure. BCSCs differ by molecular subtype, including marker profiles, prognoses, and treatment responsiveness. The review focuses on diagnostic and therapeutic strategies targeting Wnt, Notch, Hedgehog, PI3K/Akt/mTOR, and HER2 pathways to eliminate both tumor mass and stem-like subpopulations.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/breast-cancer-stem-cells-and-tumor-heterogeneity-characteristics-and-therapeutic-strategies/339698/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/breast-cancer-stem-cells-and-tumor-heterogeneity-characteristics-and-therapeutic-strategies/339698.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are breast cancer stem cells (BCSCs) important in tumor progression and treatment outcomes?","Question",{"text":113,"@type":114},"BCSCs represent a subpopulation with self-renewal capacity and differentiation potential. Their presence and subtype-dependent behavior are linked to poor outcomes and therapeutic failure.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does breast cancer heterogeneity affect diagnosis and therapy?",{"text":118,"@type":114},"Breast cancer shows diverse histological types, molecular characteristics, and clinical profiles. Differences in genomic, epigenomic, transcriptomic, and proteomic features influence proliferation, apoptosis, metastasis, and therapeutic response.",{"name":120,"@type":111,"acceptedAnswer":121},"Which signaling pathways are highlighted for therapeutic strategies targeting BCSCs?",{"text":122,"@type":114},"The document emphasizes targeting Wnt, Notch, Hedgehog, PI3K/Akt/mTOR, and HER2 signaling pathways to support effective elimination of cancer cells and BCSC subpopulations.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339698,1790479973,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","cancers   \nReview  \nBreast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies  \nAleksandra Romaniuk-Drapała, Ewa Toto ´n , Magdalena Taube , Malgorzata Idzik, Błaej Rubi´s and Natalia Lisiak *  \nCitation: Romaniuk-Drapała, A.; Toto ´n, E.; Taube, M.; Idzik, M.; Rubi´s, B.; Lisiak, N. Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies. Cancers 2024, 16, 2481 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers16132481  \nAcademic Editor: Anders M. Ström  \nReceived: 3 June 2024  \nRevised: 27 June 2024  \nAccepted: 5 July 2024  \nPublished: 7 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Clinical Chemistry and Molecular Diagnostics, Poznan University of Medical Sciences, Collegium Pharmaceuticum, Rokietnicka Str. 3, 60-806 Poznan, Poland; [aromaniuk@ump.edu.pl](aromaniuk@ump.edu.pl) (A.R.-D.);  \n[etoton@ump.edu.pl](etoton@ump.edu.pl) (E.T.); [magdalena.taube@ump.edu.pl](magdalena.taube@ump.edu.pl) (M.T.); [gosiq254@gmail.com](gosiq254@gmail.com) (M.I.);  \n[blazejr@ump.edu.pl](blazejr@ump.edu.pl) (B.R.)  \n* [Correspondence: nlisiak@ump.edu.pl](Correspondence: nlisiak@ump.edu.pl); Tel.: +48-61-641-8308  \nSimple Summary: Breast cancer stem cells (BCSCs) are a small population of cells in breast cancer tumors, playing a putative role in the cancer’s progression. BCSC biomarkers are associated with cells’enhanced growth, adhesion, migration, and invasion potential and are responsible for poor outcomes. Due to the vast heterogeneity of breast cancer signaling pathways and associated therapeutic targets, treatment strategies vary and depend on the molecular subtype of BC. Nevertheless, drugs affecting the Wnt, Notch, Hedgehog, PI3K/Akt/mTOR, and HER2 signaling pathways have been effectively applied in BCSC elimination strategies. The complexity of the characteristics of each molecular subtype of breast cancer, with an emphasis on the involvement of breast cancer stem cells in the development, metastasis, and recurrence of the tumor, requires greater understanding. Continuous updating of knowledge and the development of new therapies will allow the effective elimination of cancer cells and the rapid recovery of patients.  \nAbstract: Breast cancer is one of the most frequently detected malignancies worldwide. It is responsible for more than 15% of all death cases caused by cancer in women. Breast cancer is a heterogeneous disease representing various histological types, molecular characteristics, and clinical profiles. However, all breast cancers are organized in a hierarchy of heterogeneous cell populations, with a small proportion of cancer stem cells (breast cancer stem cells (BCSCs)) playing a putative role in cancer progression, and they are responsible for therapeutic failure. In different molecular subtypes of breast cancer, they present different characteristics, with specific marker profiles, prognoses, and treatments. Recent efforts have focused on tackling the Wnt, Notch, Hedgehog, PI3K/Akt/mTOR, and HER2 signaling pathways. Developing diagnostics and therapeutic strategies enables more efficient elimination of the tumor mass together with the stem cell population. Thus, the knowledge about appropriate therapeutic methods targeting both “normal” breast cancer cells and breast cancer stem cell subpopulations is crucial for success in cancer elimination.  \nKeywords: breast cancer subtypes; BCSC; biomarkers; signaling pathways; therapy  \n1. Introduction  \nBreast cancer (BC) became the most common cancer globally as of 2022, accounting for 11.6% of all new annual cancer cases worldwide in","cbCaimwHdj8Pf2bm","https://ap.wps.com/l/cbCaimwHdj8Pf2bm","pdf",739004,"English","# Introduction\n## Breast cancer heterogeneity and key risk/prognostic factors\n## Breast cancer stem cells (BCSCs) and their role in aggressiveness\n## Signaling pathways and therapeutic targeting","[{\"question\":\"Why are breast cancer stem cells (BCSCs) important in tumor progression and treatment outcomes?\",\"answer\":\"BCSCs represent a subpopulation with self-renewal capacity and differentiation potential. Their presence and subtype-dependent behavior are linked to poor outcomes and therapeutic failure.\"},{\"question\":\"How does breast cancer heterogeneity affect diagnosis and therapy?\",\"answer\":\"Breast cancer shows diverse histological types, molecular characteristics, and clinical profiles. Differences in genomic, epigenomic, transcriptomic, and proteomic features influence proliferation, apoptosis, metastasis, and therapeutic response.\"},{\"question\":\"Which signaling pathways are highlighted for therapeutic strategies targeting BCSCs?\",\"answer\":\"The document emphasizes targeting Wnt, Notch, Hedgehog, PI3K/Akt/mTOR, and HER2 signaling pathways to support effective elimination of cancer cells and BCSC subpopulations.\"}]","Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies | PDF",1790031676,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49203992396d37d3a455aded66d63a74.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa105a4d8c5c63e1f7ed1cf4c895be2b.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a6b4f05fd7bbfe8a553aeda42e2b382.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea6328e7faa4deb2c111b72b0a39851c.webp",980,1385]